Get the Stockscreener App
103.41
0.39%
0.395
Netflix Inc stock is traded at $103.41, with a volume of 14.91M.
It is up +0.39% in the last 24 hours and up +8.50% over the past month.
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
See More
Previous Close:
$103.01
Open:
$103.032
24h Volume:
14.91M
Relative Volume:
0.32
Market Cap:
$436.57B
Revenue:
$45.27B
Net Income/Loss:
$10.98B
P/E Ratio:
40.92
EPS:
2.5272
Net Cash Flow:
$9.46B
1W Performance:
+4.53%
1M Performance:
+8.50%
6M Performance:
-15.17%
1Y Performance:
+12.62%
1-Day Range:
$102.06
$103.67
1-Week Range:
$97.44
$103.67
52-Week Range:
$75.01
$134.12
Netflix Inc Stock (NFLX) Company Profile
Name
Netflix Inc
Sector
Industry
Phone
408-540-3700
Address
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX vs DIS, WBD, LYV, FOXA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NFLX
Netflix Inc
|
103.40 | 434.92B | 45.27B | 10.98B | 9.46B | 2.5272 |
DIS
Walt Disney Co
|
101.13 | 175.68B | 95.62B | 13.27B | 7.06B | 6.7872 |
WBD
Warner Bros Discovery Inc
|
27.39 | 68.79B | 37.32B | 749.00M | 3.09B | 0.2873 |
LYV
Live Nation Entertainment Inc
|
166.14 | 37.71B | 25.20B | 139.94M | 304.98M | -0.2348 |
FOXA
Fox Corporation
|
62.62 | 25.96B | 16.58B | 1.93B | 2.31B | 4.1552 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-06-26 | Upgrade | Goldman | Neutral → Buy |
| Mar-30-26 | Initiated | Citizens | Mkt Perform |
| Mar-24-26 | Upgrade | Erste Group | Hold → Buy |
| Mar-18-26 | Resumed | Citigroup | Buy |
| Mar-09-26 | Resumed | Wells Fargo | Equal Weight |
| Mar-02-26 | Resumed | Barclays | Equal Weight |
| Mar-02-26 | Resumed | JP Morgan | Overweight |
| Feb-27-26 | Upgrade | Arete | Neutral → Buy |
| Feb-27-26 | Resumed | Evercore ISI | Outperform |
| Jan-23-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-21-26 | Reiterated | Canaccord Genuity | Buy |
| Jan-21-26 | Reiterated | Deutsche Bank | Hold |
| Jan-21-26 | Reiterated | Goldman | Neutral |
| Jan-21-26 | Reiterated | Guggenheim | Buy |
| Jan-21-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-21-26 | Reiterated | Morgan Stanley | Overweight |
| Jan-21-26 | Reiterated | Needham | Buy |
| Jan-21-26 | Reiterated | Oppenheimer | Outperform |
| Jan-21-26 | Reiterated | Piper Sandler | Overweight |
| Jan-21-26 | Reiterated | Pivotal Research Group | Hold |
| Jan-21-26 | Reiterated | Rosenblatt | Neutral |
| Jan-21-26 | Reiterated | Rothschild & Co Redburn | Buy |
| Jan-21-26 | Reiterated | TD Cowen | Buy |
| Jan-21-26 | Reiterated | UBS | Buy |
| Jan-21-26 | Reiterated | Wolfe Research | Outperform |
| Jan-12-26 | Initiated | HSBC Securities | Buy |
| Jan-09-26 | Reiterated | Goldman | Neutral |
| Dec-08-25 | Downgrade | Pivotal Research Group | Buy → Hold |
| Dec-08-25 | Downgrade | Rosenblatt | Buy → Neutral |
| Nov-18-25 | Reiterated | Barclays | Equal Weight |
| Oct-31-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-07-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Sep-17-25 | Upgrade | Loop Capital | Hold → Buy |
| Jul-10-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-07-25 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jul-02-25 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-25 | Reiterated | Goldman | Neutral |
| Jun-20-25 | Reiterated | Pivotal Research Group | Buy |
| Jun-12-25 | Reiterated | Oppenheimer | Outperform |
| Jun-03-25 | Reiterated | Jefferies | Buy |
| May-30-25 | Reiterated | BofA Securities | Buy |
| May-19-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-21-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-21-25 | Reiterated | Barclays | Equal Weight |
| Apr-21-25 | Reiterated | Canaccord Genuity | Buy |
| Apr-21-25 | Reiterated | Guggenheim | Buy |
| Apr-21-25 | Reiterated | JP Morgan | Overweight |
| Apr-21-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-21-25 | Reiterated | MoffettNathanson | Buy |
| Apr-21-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-21-25 | Reiterated | Oppenheimer | Outperform |
| Apr-21-25 | Reiterated | Piper Sandler | Overweight |
| Apr-21-25 | Reiterated | Pivotal Research Group | Buy |
| Apr-21-25 | Reiterated | Wells Fargo | Overweight |
| Apr-17-25 | Resumed | Piper Sandler | Overweight |
| Mar-27-25 | Initiated | FBN Securities | Outperform |
| Mar-17-25 | Upgrade | MoffettNathanson | Neutral → Buy |
| Jan-24-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-23-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-22-25 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-22-25 | Reiterated | Oppenheimer | Outperform |
| Jan-22-25 | Reiterated | Pivotal Research Group | Buy |
| Jan-22-25 | Upgrade | Rosenblatt | Neutral → Buy |
| Jan-22-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Jan-16-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Jan-15-25 | Reiterated | BMO Capital Markets | Outperform |
| Jan-15-25 | Reiterated | Oppenheimer | Outperform |
| Jan-08-25 | Reiterated | Goldman | Neutral |
| Jan-06-25 | Reiterated | Argus | Buy |
| Jan-03-25 | Reiterated | The Benchmark Company | Sell |
| Dec-19-24 | Reiterated | UBS | Buy |
| Dec-16-24 | Downgrade | Loop Capital | Buy → Hold |
| Dec-16-24 | Reiterated | Oppenheimer | Outperform |
| Dec-11-24 | Reiterated | JP Morgan | Overweight |
| Nov-20-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-18-24 | Reiterated | Needham | Buy |
| Oct-18-24 | Reiterated | Oppenheimer | Outperform |
| Oct-18-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-16-24 | Reiterated | Loop Capital | Buy |
| Oct-11-24 | Reiterated | Guggenheim | Buy |
| Oct-10-24 | Reiterated | Morgan Stanley | Overweight |
| Oct-10-24 | Reiterated | Oppenheimer | Outperform |
| Oct-07-24 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-01-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Sep-05-24 | Initiated | China Renaissance | Hold |
| Aug-30-24 | Reiterated | Pivotal Research Group | Buy |
| Jul-17-24 | Reiterated | Guggenheim | Buy |
| Jul-16-24 | Reiterated | The Benchmark Company | Sell |
| Jul-15-24 | Reiterated | BofA Securities | Buy |
| Jul-12-24 | Reiterated | JP Morgan | Overweight |
| Jul-10-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-09-24 | Reiterated | TD Cowen | Buy |
| Jul-02-24 | Reiterated | Argus | Buy |
| May-28-24 | Reiterated | Evercore ISI | Outperform |
| Apr-19-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-19-24 | Upgrade | Needham | Hold → Buy |
| Apr-19-24 | Reiterated | Pivotal Research Group | Buy |
| Apr-15-24 | Reiterated | Deutsche Bank | Hold |
| Apr-12-24 | Reiterated | Morgan Stanley | Overweight |
| Apr-12-24 | Reiterated | Piper Sandler | Neutral |
| Apr-05-24 | Reiterated | Pivotal Research Group | Buy |
| Mar-25-24 | Reiterated | Citigroup | Neutral |
| Mar-12-24 | Reiterated | Jefferies | Buy |
| Mar-11-24 | Reiterated | Oppenheimer | Outperform |
| Jan-30-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jan-25-24 | Upgrade | DZ Bank | Hold → Buy |
| Jan-24-24 | Reiterated | BMO Capital Markets | Outperform |
| Jan-24-24 | Reiterated | BofA Securities | Buy |
| Jan-24-24 | Reiterated | Canaccord Genuity | Buy |
| Jan-24-24 | Reiterated | Evercore ISI | Outperform |
| Jan-24-24 | Reiterated | Goldman | Neutral |
| Jan-24-24 | Reiterated | Guggenheim | Buy |
| Jan-24-24 | Reiterated | JP Morgan | Overweight |
| Jan-24-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-24-24 | Upgrade | Macquarie | Neutral → Outperform |
| Jan-24-24 | Reiterated | Morgan Stanley | Overweight |
| Jan-24-24 | Reiterated | Oppenheimer | Outperform |
| Jan-24-24 | Reiterated | Piper Sandler | Neutral |
| Jan-24-24 | Reiterated | Pivotal Research Group | Buy |
| Jan-24-24 | Reiterated | Redburn Atlantic | Buy |
| Jan-24-24 | Reiterated | Robert W. Baird | Outperform |
| Jan-24-24 | Reiterated | TD Cowen | Outperform |
| Jan-24-24 | Reiterated | UBS | Buy |
| Jan-24-24 | Reiterated | Wells Fargo | Overweight |
| Sep-18-23 | Reiterated | Evercore ISI | Outperform |
| Aug-25-23 | Upgrade | Loop Capital | Hold → Buy |
| Jul-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-17-23 | Reiterated | Deutsche Bank | Buy |
| Jul-13-23 | Reiterated | JP Morgan | Overweight |
| Jul-12-23 | Reiterated | UBS | Buy |
| Jul-05-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-29-23 | Reiterated | Citigroup | Buy |
| Jun-28-23 | Reiterated | Oppenheimer | Outperform |
| Jun-13-23 | Reiterated | BofA Securities | Buy |
| Jun-13-23 | Reiterated | Guggenheim | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Jefferies | Buy |
| Apr-19-23 | Reiterated | Piper Sandler | Neutral |
| Apr-19-23 | Reiterated | Pivotal Research Group | Buy |
| Apr-19-23 | Reiterated | Rosenblatt | Neutral |
| Apr-19-23 | Upgrade | UBS | Neutral → Buy |
| Apr-11-23 | Resumed | Robert W. Baird | Neutral |
| Jan-23-23 | Reiterated | Argus | Buy |
| Jan-20-23 | Reiterated | Canaccord Genuity | Buy |
| Jan-20-23 | Reiterated | Deutsche Bank | Buy |
| Jan-20-23 | Reiterated | Evercore ISI | Outperform |
| Jan-20-23 | Reiterated | Goldman | Sell |
| Jan-20-23 | Reiterated | Guggenheim | Buy |
| Jan-20-23 | Reiterated | Jefferies | Buy |
| Jan-20-23 | Reiterated | MoffettNathanson | Market Perform |
| Jan-20-23 | Reiterated | Oppenheimer | Outperform |
| Jan-20-23 | Reiterated | Piper Sandler | Neutral |
| Jan-20-23 | Reiterated | Pivotal Research Group | Buy |
| Jan-20-23 | Reiterated | Robert W. Baird | Neutral |
| Jan-20-23 | Reiterated | The Benchmark Company | Sell |
| Jan-20-23 | Reiterated | Wedbush | Outperform |
| Jan-20-23 | Reiterated | Wolfe Research | Outperform |
| Jan-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-04-23 | Initiated | New Street | Neutral |
| Dec-29-22 | Upgrade | CFRA | Sell → Buy |
| Dec-14-22 | Reiterated | Jefferies | Hold |
| Dec-09-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-14-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Jun-10-22 | Downgrade | Goldman | Neutral → Sell |
| May-16-22 | Upgrade | Wedbush | Neutral → Outperform |
| Apr-21-22 | Downgrade | DZ Bank | Buy → Hold |
| Apr-21-22 | Downgrade | Edward Jones | Buy → Hold |
| Apr-20-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-20-22 | Downgrade | BofA Securities | Buy → Underperform |
| Apr-20-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-20-22 | Upgrade | Needham | Underperform → Hold |
| Apr-20-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-20-22 | Downgrade | Pivotal Research Group | Buy → Sell |
| Apr-20-22 | Downgrade | Stifel | Buy → Hold |
| Apr-20-22 | Downgrade | UBS | Buy → Neutral |
| Apr-20-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-19-22 | Initiated | Rosenblatt | Neutral |
| Mar-09-22 | Upgrade | Wedbush | Underperform → Neutral |
| Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-31-22 | Upgrade | Edward Jones | Hold → Buy |
| Jan-24-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-21-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-21-22 | Reiterated | BofA Securities | Buy |
| Jan-21-22 | Reiterated | Canaccord Genuity | Buy |
| Jan-21-22 | Reiterated | Cowen | Outperform |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Goldman | Neutral |
| Jan-21-22 | Reiterated | Guggenheim | Buy |
| Jan-21-22 | Reiterated | JP Morgan | Overweight |
| Jan-21-22 | Reiterated | MoffettNathanson | Neutral |
| Jan-21-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Jan-21-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-21-22 | Reiterated | Oppenheimer | Outperform |
| Jan-21-22 | Reiterated | Piper Sandler | Overweight |
| Jan-21-22 | Reiterated | Pivotal Research Group | Buy |
| Jan-21-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Upgrade | The Benchmark Company | Sell → Hold |
| Jan-21-22 | Downgrade | Truist | Buy → Hold |
| Jan-21-22 | Reiterated | UBS | Buy |
| Jan-21-22 | Reiterated | Wolfe Research | Outperform |
| Dec-15-21 | Reiterated | The Benchmark Company | Sell |
| Oct-20-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Sep-29-21 | Reiterated | The Benchmark Company | Sell |
| Sep-13-21 | Initiated | Goldman | Neutral |
| Sep-08-21 | Reiterated | JP Morgan | Overweight |
| Sep-07-21 | Reiterated | Atlantic Equities | Overweight |
| Jul-21-21 | Reiterated | Credit Suisse | Outperform |
| Jul-21-21 | Reiterated | Deutsche Bank | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jun-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-25-21 | Initiated | Edward Jones | Hold |
| May-19-21 | Resumed | Jefferies | Buy |
| Apr-21-21 | Resumed | Oppenheimer | Outperform |
| Apr-21-21 | Reiterated | Pivotal Research Group | Buy |
| Apr-21-21 | Upgrade | Stifel | Hold → Buy |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Apr-01-21 | Initiated | Piper Sandler | Overweight |
| Mar-25-21 | Reiterated | The Benchmark Company | Sell |
| Mar-23-21 | Upgrade | Argus | Hold → Buy |
| Jan-21-21 | Upgrade | DZ Bank | Hold → Buy |
| Jan-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Jan-20-21 | Reiterated | Pivotal Research Group | Buy |
| Jan-20-21 | Reiterated | The Benchmark Company | Sell |
| Jan-20-21 | Upgrade | UBS | Neutral → Buy |
| Jan-20-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-21-20 | Reiterated | BMO Capital Markets | Outperform |
| Oct-21-20 | Reiterated | Bernstein | Outperform |
| Oct-21-20 | Reiterated | Jefferies | Buy |
| Oct-21-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-21-20 | Reiterated | Oppenheimer | Outperform |
| Oct-21-20 | Reiterated | Piper Sandler | Overweight |
| Oct-21-20 | Reiterated | Pivotal Research Group | Buy |
| Oct-21-20 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-21-20 | Reiterated | The Benchmark Company | Sell |
| Oct-21-20 | Reiterated | Wedbush | Underperform |
| Oct-21-20 | Reiterated | Wells Fargo | Equal Weight |
| Oct-16-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-15-20 | Reiterated | Canaccord Genuity | Buy |
| Oct-14-20 | Reiterated | Goldman | Buy |
| Oct-07-20 | Reiterated | Pivotal Research Group | Buy |
| Sep-28-20 | Reiterated | The Benchmark Company | Sell |
| Sep-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-20 | Resumed | Raymond James | Mkt Perform |
| Sep-04-20 | Reiterated | The Benchmark Company | Sell |
| Jul-29-20 | Reiterated | Loop Capital | Buy |
View All
Netflix Inc Stock (NFLX) Latest News
3 Big Reasons Netflix Will Continue to Soar - Yahoo Finance
3 Company Earnings to Watch This Week (April 13-17) - The Motley Fool
Bullish Outlook for Netflix's Advertising Business - Intellectia AI
Netflix wins sell-side praise for ad potential, content quality (NFLX:NASDAQ) - Seeking Alpha
Rep. Byron Donalds Buys Netflix Shares - National Today
Netflix Earnings Could Make These ETFs Entertaining - ETF Trends
Netflix Q1 Preview: Analyst Expects Ad Revenues To Exceed $3BNetflix (NASDAQ:NFLX) - Benzinga
5 Stocks That Can Break Your Heart This Week: None of Them Are Banks - The Motley Fool
UK to probe Paramount-Warner Bros deal in coming weeks, competition watchdog says - Reuters
Netflix Before Q1 Earnings: Should Investors Buy the Stock Now? - Zacks Investment Research
Netflix Stock Forecast: Trending Strong Buy Among Analysts - TipRanks
Wedbush Raises Netflix Stock (NFLX) Price Target Ahead of Q1 Earnings — Sees Strong Ad Momentum - TipRanks
RFG Holdings Inc. Boosts Netflix Stake by 962% - National Today
Netflix To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Netflix, Inc. $NFLX Shares Purchased by Whitener Capital Management Inc. - MarketBeat
U.S. Capital Wealth Advisors LLC Acquires 55,290 Shares of Netflix, Inc. $NFLX - MarketBeat
Guyasuta Investment Advisors Inc. Raises Position in Netflix, Inc. $NFLX - MarketBeat
Retirement Guys Formula LLC Purchases 19,797 Shares of Netflix, Inc. $NFLX - MarketBeat
Helios Capital Management PTE. Ltd. Acquires 47,400 Shares of Netflix, Inc. $NFLX - MarketBeat
Oxler Private Wealth LLC Has $1.43 Million Position in Netflix, Inc. $NFLX - MarketBeat
Going Into Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued? - Morningstar
Netflix, Inc. $NFLX Shares Purchased by FFG Partners LLC - MarketBeat
Burney Co. Raises Stake in Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Purchased by Choreo LLC - MarketBeat
Netflix, Inc. $NFLX Stock Position Raised by Baillie Gifford & Co. - MarketBeat
Netflix’s Q1 Rally Outpaces 2025 Growth – Will Earnings This Week Justify The Run-Up? - Stocktwits
ABLE Financial Group LLC Raises Stock Holdings in Netflix, Inc. $NFLX - MarketBeat
Netflix Quarterly Earnings Report: Polymarket Predictions - Action Network
Ahead of Q1 Earnings, Let’s Look at Who Owns Netflix Stock (NFLX) - TipRanks
Ahead of Netflix's (NFLX.US) earnings release, Goldman Sachs issued a bullish research report, highlighting growth drivers such as price increases, advertising, and IP enhancement. - Moomoo
HSBC Research Raises Netflix (NFLX.US) TP to USD114, Maintains Buy - AASTOCKS.com
Netflix co-founder makes shocking $500M move as new fight erupts - thestreet.com
Goldman Sachs Upgrades Netflix (NFLX) Stock to Buy from Neutral - Insider Monkey
Netflix, Inc. stock (US64110L1061): Is live events strategy strong enough to unlock new upside? - AD HOC NEWS
NBT Bank Boosts Netflix Stake by Over 650% - National Today
1 Stock to Buy, 1 Stock to Sell This Week: Netflix, Johnson & Johnson - Investing.com
Netflix: The $7.4 Billion You Won't Find In Its Debt Line — But Maybe You Should - AOL.com
Netflix Inc (NFLX) Stock Price Quote Today & Current Price Chart - Capital.com
10,520 Shares in Netflix, Inc. $NFLX Bought by Integrated Financial Solutions Inc. - MarketBeat
Robbins Farley Acquires 42,363 Shares of Netflix, Inc. $NFLX - MarketBeat
KG&L Capital Management LLC Purchases 18,075 Shares of Netflix, Inc. $NFLX - MarketBeat
Sumitomo Mitsui Trust Group Inc. Buys 10,879,276 Shares of Netflix, Inc. $NFLX - MarketBeat
Robeco Institutional Asset Management B.V. Purchases 1,598,242 Shares of Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Purchased by Ritholtz Wealth Management - MarketBeat
NBT Bank N A NY Purchases 36,499 Shares of Netflix, Inc. $NFLX - MarketBeat
Howard Capital Management Inc. Acquires 251,535 Shares of Netflix, Inc. $NFLX - MarketBeat
Gibbs Wealth Management Acquires 11,291 Shares of Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Acquired by Massachusetts Financial Services Co. MA - MarketBeat
Factory Mutual Insurance Co. Increases Netflix Holdings by 874% - National Today
Brown Lisle Cummings Inc. Has $3.94 Million Holdings in Netflix, Inc. $NFLX - MarketBeat
Curtis Advisory Group LLC Purchases 24,357 Shares of Netflix, Inc. $NFLX - MarketBeat
Netflix Inc Stock (NFLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
3.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):